w.novak
TL3 Regular · Brno, CZ
Engineer. I like unit arithmetic and I dislike unlabelled axes.
Joined 6 January 2025 · last posted 2d · groups: wiki-editors
125 posts, newest first. Showing up to 150.
-
Tracking intake honestly when appetite is absent Replied, post #114 · Nutrition & Training › Protein & intake · 26 Jul 2026 · 16 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Impurity thresholds: where the common numbers come from Replied, post #15 · Analytics › Impurities & related substances · 25 Jul 2026 · 20 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #35 · Clinical › Bloodwork · 25 Jul 2026 · 15 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #138 · Practice › Reconstitution · 24 Jul 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Why the Start Here categories exist, and what they are not for Replied, post #27 · Start Here › Welcome · 23 Jul 2026 · 33 likes post #26 answers the question as asked. The question underneath it is different. Off-topic posts that do not belong here belong in the Lounge instead. You are not in…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #72 · Evidence › Journal club · 22 Jul 2026 · 9 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #87 · Analytics › Impurities & related substances · 17 Jul 2026 · 3 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Retatrutide mass and identity: what a report should show Replied, post #16 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #65 · Access › Insurance & coverage · 10 Jul 2026 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Substitution between formats during a shortage — what changed since Replied, post #5 · Access › Shortages · 9 Jul 2026 · 5 likes Coming back to post #3, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #6 · Clinical › Comorbidities · 9 Jul 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #45 · Nutrition & Training › Protein & intake · 9 Jul 2026 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Follow-up: Sleep quality changes during weight loss Replied, post #54 · Wellbeing › Sleep · 26 Jun 2026 · 0 likes This follows post #51 rather than contradicting it. When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing…
-
Revisiting: What pooling buys you and what it destroys Replied, post #65 · Evidence › Meta-analyses · 23 Jun 2026 · 0 likes post #64 answers the question as asked. The question underneath it is different. Funnel plots: a plot of study effect size versus sample size that helps detect…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #67 · Practice › Storage & stability · 6 Jun 2026 · 0 likes post #66 is right about the mechanism and I think understates the practical bit. Published stability data applies specifically to the formulation studied, under the…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #24 · Access › Insurance & coverage · 28 May 2026 · 7 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Request: a per-category review queue Started this topic · Meta › Feature requests · 22 May 2026 · 0 likes Request: a per-category review queue Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #41 · Analytics › Impurities & related substances · 18 May 2026 · 7 likes On post #37 — agreed on the reasoning, with one qualification. Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #4 · Evidence › Meta-analyses · 12 May 2026 · 5 likes Worth separating two things that post #2 runs together. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #102 · Practice › Interactions · 8 May 2026 · 1 like Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
What a certificate commits its issuer to — one year on Replied, post #62 · Analytics › COA interpretation · 5 May 2026 · 18 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #84 · Devices › Syringes & needles · 3 May 2026 · 0 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Electrolyte supplements: which ones do anything Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 3 May 2026 · 22 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #40 · Sourcing › Red flags · 3 May 2026 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #107 · Compounds › Tirzepatide · 2 May 2026 · 26 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #35 · Meta › Announcements · 23 Apr 2026 · 18 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #14 · Lounge › Introductions · 18 Apr 2026 · 3 likes I read post #12 twice before replying, because I had assumed the opposite. No spam: introductions are not a place to advertise commercial products or services. That is…
-
Micro-titration: a disputed topic, argued properly Replied, post #56 · Practice › Dosing & titration · 6 Apr 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #17 · Practice › Interactions · 29 Mar 2026 · 14 likes Picking up post #14: that is the part I would want checked first. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect…
-
Designing a personal experiment that could change your mind — one year on Replied, post #24 · Research Methods › N-of-1 designs · 23 Mar 2026 · 2 likes post #23 is right about the mechanism and I think understates the practical bit. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
-
What a certificate commits its issuer to — one year on Replied, post #35 · Analytics › COA interpretation · 20 Mar 2026 · 7 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #94 · Meta › Site feedback · 9 Mar 2026 · 0 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Contributing data without breaching anyone's privacy Replied, post #29 · Data & Tools › Datasets · 4 Mar 2026 · 2 likes On post #25 — agreed on the reasoning, with one qualification. Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #30 · Practice › Storage & stability · 4 Mar 2026 · 15 likes I read post #28 twice before replying, because I had assumed the opposite. Protecting from light: amber vials or opaque containers reduce light exposure. If you are…
-
Request: export my own posts — one year on Replied, post #54 · Meta › Feature requests · 3 Mar 2026 · 0 likes On post #50 — agreed on the reasoning, with one qualification. Community support: if other people support your request, they can reply with "+1" or "I would use that…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #10 · Sourcing › Logistics · 3 Mar 2026 · 5 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Lipase elevation without symptoms: the interpretation problem Replied, post #25 · Clinical › Bloodwork · 3 Mar 2026 · 26 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Peer-to-peer review: what actually happens on the call — one year on Replied, post #6 · Access › Insurance & coverage · 2 Mar 2026 · 0 likes Picking up post #3: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #40 · Analytics › Impurities & related substances · 25 Feb 2026 · 0 likes post #39 answers the question as asked. The question underneath it is different. Off-target structures: if the sequence synthesis goes wrong, a completely different…
-
Liver enzymes drifting down and what that usually means Replied, post #60 · Clinical › Bloodwork · 24 Feb 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #60 · Practice › Dosing & titration · 18 Feb 2026 · 17 likes On post #56 — agreed on the reasoning, with one qualification. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #8 · Sourcing › Vendor reports · 18 Feb 2026 · 2 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #67 · Documentation › Wiki requests · 2 Feb 2026 · 2 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #20 · Outcomes › Body composition · 29 Jan 2026 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Maintenance phase: tracking body composition during maintenance (weight stable) is…
-
Coverage in the US: a map of the usual obstacles Replied, post #43 · Regional › North America · 29 Jan 2026 · 4 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
-
A partial dose because the pen emptied mid-injection Replied, post #72 · Practice › Administration · 9 Jan 2026 · 2 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
A partial dose because the pen emptied mid-injection Replied, post #65 · Practice › Administration · 9 Jan 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #40 · Pharmacology › Receptor biology · 3 Jan 2026 · 3 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #29 · Practice › Interactions · 2 Jan 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #34 · Devices › Pens & autoinjectors · 25 Dec 2025 · 12 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 22 Dec 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #125 · Practice › Reconstitution · 22 Dec 2025 · 3 likes On post #121 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #118 · Practice › Reconstitution · 12 Dec 2025 · 28 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #27 · Compounds › Tirzepatide · 3 Dec 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #23 · Devices › Pens & autoinjectors · 30 Nov 2025 · 27 likes Picking up post #20: that is the part I would want checked first. Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is…
-
Personal import allowances, compared — a second dataset Replied, post #26 · Access › International · 23 Nov 2025 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #45 · Analytics › Impurities & related substances · 23 Nov 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
[2026 update] What steady state means for the decision to escalate Replied, post #122 · Practice › Dosing & titration · 17 Nov 2025 · 0 likes Worth separating two things that post #118 runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Sleep quality changes during weight loss — what changed since Replied, post #55 · Wellbeing › Sleep · 8 Nov 2025 · 0 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #10 · Compounds › Retatrutide · 29 Oct 2025 · 17 likes I read post #8 twice before replying, because I had assumed the opposite. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #81 · Documentation › Doc review · 25 Oct 2025 · 10 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
A 40-week log with the measurement method stated Replied, post #60 · Outcomes › Progress reports · 24 Oct 2025 · 1 like post #59 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
New subcategory: rationale and scope Replied, post #88 · Meta › Announcements · 22 Oct 2025 · 0 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
New subcategory: rationale and scope Replied, post #63 · Meta › Announcements · 19 Oct 2025 · 3 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #92 · Practice › Storage & stability · 19 Oct 2025 · 19 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #31 · Practice › Interactions · 13 Oct 2025 · 0 likes On post #27 — agreed on the reasoning, with one qualification. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #114 · Practice › Side effects · 3 Oct 2025 · 3 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #18 · Evidence › Preprints · 26 Sep 2025 · 21 likes Worth separating two things that post #14 runs together. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #7 · Evidence › Preprints · 25 Sep 2025 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Dead volume across syringe and needle combinations Replied, post #4 · Devices › Syringes & needles · 23 Sep 2025 · 6 likes Worth separating two things that post #2 runs together. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub).…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #81 · Practice › Side effects · 9 Sep 2025 · 0 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #6 · marked as the solution · Analytics › Impurities & related substances · 5 Sep 2025 · 7 likes post #5 answers the question as asked. The question underneath it is different. Residual solvents: traces of solvents used in purification. These are usually tested by…
-
A request that was declined, and the reasoning — a second dataset Replied, post #97 · Documentation › Wiki requests · 15 Aug 2025 · 3 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
A request that was declined, and the reasoning — a second dataset Replied, post #50 · Documentation › Wiki requests · 11 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #80 · Outcomes › Progress reports · 15 Jul 2025 · 16 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #67 · Clinical › Comorbidities · 8 Jul 2025 · 17 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Checking someone else's arithmetic: a worked example thread Replied, post #62 · Practice › Reconstitution · 29 Jun 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Coming back to: When "no data" is the complete and final answer Replied, post #27 · Compounds › Other compounds · 28 Jun 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Compounds this community declines to help with, and why: there are specifics in the…
-
A report I filed that turned out to be wrong, and the correction Replied, post #118 · Sourcing › Vendor reports · 23 Jun 2025 · 8 likes post #117 answers the question as asked. The question underneath it is different. Blind submission is worth the effort: have someone else relabel the sample so neither…
-
Counter-ion content and its effect on measured mass Replied, post #67 · Analytics › Mass spectrometry · 17 Jun 2025 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Half-life, steady state, and accumulation worked through Replied, post #109 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 2 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #33 · Access › Insurance & coverage · 9 Jun 2025 · 0 likes Coming back to post #31, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most…
-
Which panel is worth repeating and which is worth ignoring Replied, post #32 · Clinical › Bloodwork · 5 Jun 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Sequence verification for an obscure compound: how it is done Replied, post #51 · Compounds › Other compounds · 2 Jun 2025 · 3 likes post #50 is right about the mechanism and I think understates the practical bit. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #3 · Sourcing › Vendor reports · 17 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #96 · Sourcing › Red flags · 16 May 2025 · 2 likes This follows post #93 rather than contradicting it. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's…
-
Reading an MS report that only gives you a single number Replied, post #77 · Analytics › Mass spectrometry · 12 May 2025 · 0 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #17 · Practice › Reconstitution · 9 May 2025 · 15 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #15 · Evidence › Trials · 21 Apr 2025 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
When to suspect the method rather than the sample Replied, post #116 · Analytics › Method validation · 17 Apr 2025 · 21 likes I read post #114 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #92 · Evidence › Journal club · 7 Apr 2025 · 15 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Storing a pen in use versus a pen unopened Replied, post #6 · Devices › Pens & autoinjectors · 4 Apr 2025 · 17 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Coverage for the indication versus for the drug Replied, post #16 · Access › Insurance & coverage · 1 Apr 2025 · 1 like Coming back to post #14, because the follow-up matters more than the original answer. Tier placement and step therapy: some formularies place a medication on a higher…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #66 · Practice › Reconstitution · 29 Mar 2025 · 15 likes Worth separating two things that post #62 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #37 · Access › Insurance & coverage · 23 Mar 2025 · 27 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #71 · Documentation › Doc review · 23 Mar 2025 · 0 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #126 · Pharmacology › Receptor biology · 19 Mar 2025 · 13 likes Picking up post #123: that is the part I would want checked first. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #76 · Sourcing › Vendor reports · 17 Mar 2025 · 3 likes On post #72 — agreed on the reasoning, with one qualification. Structured report format: compound, lot, independent testing service, method as reported, result, and the…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #37 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes post #36 answers the question as asked. The question underneath it is different. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
-
Reading order for a first week here, and what to skip until later Replied, post #32 · Start Here › Welcome · 11 Mar 2025 · 27 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #9 · Practice › Administration · 6 Mar 2025 · 9 likes post #8 answers the question as asked. The question underneath it is different. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #102 · Compounds › Other compounds · 28 Feb 2025 · 4 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Scheduled maintenance and what will be unavailable Replied, post #57 · Meta › Announcements · 28 Feb 2025 · 1 like Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #20 · Access › Pricing · 27 Feb 2025 · 0 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #100 · Compounds › Other compounds · 26 Feb 2025 · 9 likes Coming back to post #98, because the follow-up matters more than the original answer. When "no data" is the complete and final answer: if there is no published human…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #135 · Evidence › Journal club · 21 Feb 2025 · 5 likes On post #131 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it…
-
Prior authorisation: what the criteria usually require Replied, post #7 · Access › Insurance & coverage · 17 Feb 2025 · 0 likes post #6 answers the question as asked. The question underneath it is different. Reimbursement changes: a compound covered one year might not be the next. A formulary…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #32 · Access › International · 7 Feb 2025 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Triple agonism: additive, synergistic, or neither? Replied, post #12 · Compounds › Retatrutide · 21 Jan 2025 · 5 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
[2026 update] New subcategory: rationale and scope Replied, post #96 · Meta › Announcements · 26 Dec 2024 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Started this topic · Compounds › Repair & healing peptides · 18 Dec 2024 · 7 likes On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. I have…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #13 · Documentation › Doc review · 9 Dec 2024 · 19 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Why quantitation is the hard part, not detection Replied, post #2 · Analytics › Home & field testing · 8 Dec 2024 · 1 like the opening post is right about the mechanism and I think understates the practical bit. Precision of home tests: most consumer-accessible devices are not precise to…
-
People with a low starting BMI: where the evidence stops Replied, post #16 · Clinical › Special populations · 17 Nov 2024 · 0 likes Picking up post #13: that is the part I would want checked first. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #34 · Sourcing › Independent verification · 16 Nov 2024 · 9 likes Worth separating two things that post #30 runs together. How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity,…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #66 · Compounds › Repair & healing peptides · 16 Nov 2024 · 8 likes On post #62 — agreed on the reasoning, with one qualification. For anyone arriving from search engines: this subcategory discusses published preclinical work and the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #31 · Compounds › Repair & healing peptides · 11 Nov 2024 · 18 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #6 · Compounds › Tirzepatide · 22 Oct 2024 · 4 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
What a seizure notice actually says Replied, post #2 · Sourcing › Logistics · 12 Oct 2024 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #65 · Practice › Dosing & titration · 17 Sep 2024 · 17 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #7 · Practice › Interactions · 10 Sep 2024 · 6 likes Picking up post #4: that is the part I would want checked first. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #9 · Compounds › Secretagogues & GH axis · 8 Sep 2024 · 15 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #2 · Compounds › Tirzepatide · 16 Aug 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #3 · Analytics › Method validation · 13 Jul 2024 · 8 likes Coming back to the opening post, because the follow-up matters more than the original answer. Specificity: the method can distinguish the intended compound from related…
-
Follow-up: Why this community will not facilitate a group purchase Started this topic · Sourcing › Payments · 11 Jul 2024 · 0 likes Why this community will not facilitate a group purchase I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question,…